Table 1.
Clinicopathological feature | NF-κB expression | P-value | Notch1 expression | P-value | |||
---|---|---|---|---|---|---|---|
High | Low | High | Low | ||||
Gender | |||||||
Male | 21 | 25 | 0.451 | 22 | 24 | 0.887 | |
Female | 8 | 6 | 7 | 7 | |||
Age (years) | |||||||
≤ 60 | 17 | 23 | 0.201 | 23 | 17 | 0.058 | |
> 60 | 12 | 8 | 6 | 14 | |||
Differentiation | |||||||
Well | 7 | 8 | 0.231 | 3 | 12 | 0.001 | |
Moderate | 16 | 11 | 10 | 17 | |||
Poor | 6 | 12 | 16 | 2 | |||
TNM stages | |||||||
I + II | 8 | 12 | 0.361 | 10 | 10 | 0.855 | |
III | 21 | 19 | 19 | 21 | |||
Lymphatic metastasis | |||||||
With | 23 | 2 | 0.001 | 6 | 19 | 0.001 | |
Without | 6 | 29 | 23 | 12 | |||
LVD (VEGF-R3) | |||||||
High | 19 | 12 | 0.038 | 10 | 21 | 0.010 | |
Low | 10 | 19 | 19 | 10 | |||
Podoplanin | |||||||
High | 20 | 10 | 0.004 | 8 | 19 | 0.008 | |
Low | 9 | 21 | 21 | 12 | |||
VEGF-C expression | |||||||
High | 18 | 11 | 0.039 | 6 | 23 | 0.001 | |
Low | 11 | 20 | 23 | 8 | |||
Notch1 expression | |||||||
High | 8 | 21 | 0.002 | ||||
Low | 10 | 21 |